ETV Bharat / lifestyle

Indian health experts differ on booster dose amid Omicron surge

Health experts are divided on the booster dose. Some say frontline health care workers and vulnerable populations should get the booster dose first while others think the government should ensure at least one dose to all eligible people before taking a final call on the booster dose.

Dr Suneela Garg,  President of the Indian Association of Preventive and Social Medicine
Dr Suneela Garg, President of the Indian Association of Preventive and Social Medicine
author img

By

Published : Dec 21, 2021, 9:48 PM IST

Updated : Dec 21, 2021, 10:18 PM IST

New Delhi: Even two consecutive meetings of the National Technical Advisory Group on Immunization (NATGI) yield no consensus over booster dose, experts from India's heath domain seems to have differences of opinion regarding booster dose.

Some health experts and academicians suggest that government should ensure at least one dose to all eligible people before taking a final call on booster dose. Other experts, however, opined that frontline health care workers and vulnerable populations should get the booster dose first.

Talking to ETV Bharat, President of the Indian Association of Preventive and Social Medicine (IAPSM) Dr Suneela Garg said that it is necessary to ensure at least one side of the vaccine to the eligible population.

"Studies till date indicate that our present two vaccines can fight the Covid19 variants and as the government says, it's very urgent to complete one dose of vaccines to our entire population," said Dr Garg.

Dr Suneela Garg, President of the Indian Association of Preventive and Social Medicine

She highlighted that a large chunk of the Indian population already got natural immunity. "A large number of people suffered in the second wave automatically getting antibodies and after vaccination, their immunity got a boost," said Dr Garg.

"Our priority should be vaccinating the rest of the population. We should also think about where we can send vaccines and where it is needed," said Dr Garg and added, "Government is at the same time examining on the booster dose."

Sources in the Health Ministry told ETV Bharat that ensuring one dose of the Covid19 vaccine was the major issue over which the NTAGI members have emphasised.

Minister of State for Health and Family Welfare Dr Bharati Pravin Pawar said that while there is no evidence to suggest that existing vaccines do not work on Omicron, some of the mutations reported on the Spike gene may presumably decrease the efficacy of existing vaccines.

"Vaccines are expected to provide protection against severe disease and vaccination with the available vaccines is crucial," said Dr Pawar.

"The recent emergence of the Omicron variant emphasizes the importance of vaccination, booster, as well as prevention efforts to protect against Covid19," said Dr Tamorish Kole, president of Asian Society of Emergency Medicine.

Quoting reports, Dr Kole said that among healthcare and front line workers, vaccine effectiveness against Covid-19 infection is also decreasing over time.

Total Omicron cases in India

As of Tuesday, India reported at least 202 cases of Omicron (B.1.1.529) from 13 States and UTs. Maharashtra and Delhi with 56 such cases each are leading the list of States registering Omicron cases.

Globally 96 countries have reported Omicron cases.

As per "Our World in Data" statistics, Omicron share 8 per cent of analysed SARS-CoV-2 sequences with 92 per cent of variant belonging to Delta and others.

The United Kingdom bears the maximum burden of Omicron cases with 37 per cent followed by the United States 19 per cent.

As per government statistics, a total of 1,38,93,00,402 vaccines have been administered to date in India out of which 83,13,43,684 got the first dose and 55,79, 56,718 got the second dose.

The currently available RT PCR tests for Covid19 has been validated to detect the Omicron variant. Owing to a high number of mutations, the variant carries a higher risk of transmission.

Omicron was declared as Voice of Concern (VoC) by the World Health Organisation (WHO) on November 26 after the variant was first reported in South Africa on November 24.

Also Read: No evidence that Omicron has lower severity than Delta variant: UK study

New Delhi: Even two consecutive meetings of the National Technical Advisory Group on Immunization (NATGI) yield no consensus over booster dose, experts from India's heath domain seems to have differences of opinion regarding booster dose.

Some health experts and academicians suggest that government should ensure at least one dose to all eligible people before taking a final call on booster dose. Other experts, however, opined that frontline health care workers and vulnerable populations should get the booster dose first.

Talking to ETV Bharat, President of the Indian Association of Preventive and Social Medicine (IAPSM) Dr Suneela Garg said that it is necessary to ensure at least one side of the vaccine to the eligible population.

"Studies till date indicate that our present two vaccines can fight the Covid19 variants and as the government says, it's very urgent to complete one dose of vaccines to our entire population," said Dr Garg.

Dr Suneela Garg, President of the Indian Association of Preventive and Social Medicine

She highlighted that a large chunk of the Indian population already got natural immunity. "A large number of people suffered in the second wave automatically getting antibodies and after vaccination, their immunity got a boost," said Dr Garg.

"Our priority should be vaccinating the rest of the population. We should also think about where we can send vaccines and where it is needed," said Dr Garg and added, "Government is at the same time examining on the booster dose."

Sources in the Health Ministry told ETV Bharat that ensuring one dose of the Covid19 vaccine was the major issue over which the NTAGI members have emphasised.

Minister of State for Health and Family Welfare Dr Bharati Pravin Pawar said that while there is no evidence to suggest that existing vaccines do not work on Omicron, some of the mutations reported on the Spike gene may presumably decrease the efficacy of existing vaccines.

"Vaccines are expected to provide protection against severe disease and vaccination with the available vaccines is crucial," said Dr Pawar.

"The recent emergence of the Omicron variant emphasizes the importance of vaccination, booster, as well as prevention efforts to protect against Covid19," said Dr Tamorish Kole, president of Asian Society of Emergency Medicine.

Quoting reports, Dr Kole said that among healthcare and front line workers, vaccine effectiveness against Covid-19 infection is also decreasing over time.

Total Omicron cases in India

As of Tuesday, India reported at least 202 cases of Omicron (B.1.1.529) from 13 States and UTs. Maharashtra and Delhi with 56 such cases each are leading the list of States registering Omicron cases.

Globally 96 countries have reported Omicron cases.

As per "Our World in Data" statistics, Omicron share 8 per cent of analysed SARS-CoV-2 sequences with 92 per cent of variant belonging to Delta and others.

The United Kingdom bears the maximum burden of Omicron cases with 37 per cent followed by the United States 19 per cent.

As per government statistics, a total of 1,38,93,00,402 vaccines have been administered to date in India out of which 83,13,43,684 got the first dose and 55,79, 56,718 got the second dose.

The currently available RT PCR tests for Covid19 has been validated to detect the Omicron variant. Owing to a high number of mutations, the variant carries a higher risk of transmission.

Omicron was declared as Voice of Concern (VoC) by the World Health Organisation (WHO) on November 26 after the variant was first reported in South Africa on November 24.

Also Read: No evidence that Omicron has lower severity than Delta variant: UK study

Last Updated : Dec 21, 2021, 10:18 PM IST
ETV Bharat Logo

Copyright © 2024 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.